Merck & Co., Inc: Parkinson Disease trials
The registry lists 12 Parkinson Disease studies with Merck & Co., Inc as lead sponsor. 0 are open to participants now and 10 have results posted.
Phase 1 5Phase 2 3Phase 3 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess Pharmacokinetics of Preladenant in Participants With Chronic Hepatic Impairment (P06513)CompletedNCT01465412Phase 1Results posted
- A Study to Assess Pharmacokinetics (PK) of Preladenant in Participants With Chronic Renal Impairment (CRI) (P06512)CompletedNCT01323855Phase 1Results posted
- A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)CompletedNCT01294800Phase 2Results posted
- Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)CompletedNCT01227265Phase 3Results posted
- An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)TerminatedNCT01215227Phase 3Results posted
- A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664)TerminatedNCT01155479Phase 3Results posted
- A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938)CompletedNCT01155466Phase 3Results posted
- Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)CompletedNCT00845000Phase 1Results posted
- Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)CompletedNCT00537017Phase 2Results posted
- Dyskinesia in Parkinson's Disease (Study P04501)CompletedNCT00406029Phase 2Results posted
- Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235)WithdrawnNCT01500707Phase 1
- A Study of MK0657 in Parkinson's Disease Patients (0657-006)CompletedNCT00505843Phase 1